Literature DB >> 16380294

Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies?

Frederico G C Abath1, Clarice N L Morais, Carlos Eduardo L Montenegro, Thomas A Wynn, Silvia M L Montenegro.   

Abstract

Studies in mice indicate that schistosome egg-induced granuloma formation and hepatic fibrosis depend markedly on cytokine regulation, with interleukin 10 having a central role. There is no clear consensus about the pattern of cytokine production and regulation that causes a minority of chronically exposed patients to develop severe hepatosplenic (HS) disease, which is characterized by periportal fibrosis and portal hypertension. HS disease and the progression of hepatic fibrosis are associated with the production of profibrotic type 2 cytokines in the early stages of infection with Schistosoma mansoni. However, other studies indicate that HS disease is characterized by a predominant T helper 1 profile. Until new tools and approaches are developed to study human disease in endemic areas, investigators must either speculate about indirect evidence from human studies or rely more heavily on findings generated from experimental models of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380294     DOI: 10.1016/j.pt.2005.12.004

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  32 in total

Review 1.  New insights into gastrointestinal and hepatic granulomatous disorders.

Authors:  Majid A Almadi; Abdulrahman M Aljebreen; Faisal M Sanai; Victoria Marcus; Ebtissam S Almeghaiseeb; Subrata Ghosh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-05       Impact factor: 46.802

2.  Specific humoral response of hosts with variable schistosomiasis susceptibility.

Authors:  Patrick Driguez; Hamish E G McWilliam; Soraya Gaze; David Piedrafita; Mark S Pearson; Rie Nakajima; Mary Duke; Angela Trieu; Denise L Doolan; Fernanda C Cardoso; Algis Jasinskas; Geoffrey N Gobert; Philip L Felgner; Alex Loukas; Els Meeusen; Donald P McManus
Journal:  Immunol Cell Biol       Date:  2015-06-05       Impact factor: 5.126

3.  Cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin.

Authors:  Nagwa Mostafa El-Sayed; Ghada Mahmoud Fathy; Sara Abdel-Rahman Abdel-Rahman; Mahmoud Abdel-Atei El-Shafei
Journal:  J Parasit Dis       Date:  2014-10-30

Review 4.  Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies.

Authors:  Rashad A Abdul-Ghani; Azza A Hassan
Journal:  Parasitol Res       Date:  2010-04-06       Impact factor: 2.289

Review 5.  Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam.

Authors:  Donald P McManus; Darren J Gray; Yuesheng Li; Zheng Feng; Gail M Williams; Donald Stewart; Jose Rey-Ladino; Allen G Ross
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.

Authors:  Ghada Boghdadi; Dalia Abdel Khalik; Sami Abdel Wahab; Adel Farghaly
Journal:  Parasitol Res       Date:  2012-09-20       Impact factor: 2.289

Review 7.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Charles Perkins; Fred D Finkelman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Schistosoma mansoni soluble egg antigens enhance Listeria monocytogenes vector HIV-1 vaccine induction of cytotoxic T cells.

Authors:  Cac T Bui; Lisa M Shollenberger; Yvonne Paterson; Donald A Harn
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

10.  Hepatic extracellular matrix alterations in dogs naturally infected with Leishmania (Leishmania) chagasi.

Authors:  Ferdinan Almeida Melo; Eliane Perlatto Moura; Raul Rio Ribeiro; Cíntia Fontes Alves; Marcelo Vidigal Caliari; Washington Luiz Tafuri; Kátia da Silva Calabrese; Wagner Luiz Tafuri
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.